Purchase Order 75N91020K20023
- Not listed
- This is a $24,516.05 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Harvard Bioscience Inc., through its Harvard Apparatus Division. The contract is for the delivery of specialized scientific equipment, with no set-aside designation. Harvard Bioscience is a global developer, manufacturer, and marketer of scientific products and instruments used in biomedical research across various disciplines, including neuroscience, oncology, and cardiovascular...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Harvard Bioscience Inc.'s Harvard Apparatus Division. The $5,702.25 contract is for the provision of specialized scientific products, apparatus, and instruments used in biomedical research across disciplines like neuroscience, oncology, and cardiovascular studies. The award is not a set-aside contract....
- This federal contract award to Harvard Bioscience Inc. through its Harvard Apparatus Division is for the provision of specialized scientific equipment and instruments to support biomedical research initiatives. The $22,763.00 firm fixed-price purchase order was awarded by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services. The contract includes the delivery of various catalog items such as syringe pumps, ventilators, and electrophysiology...
- This $37,914 fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Harvard Bioscience Inc.'s Harvard Apparatus division on May 17, 2021. The award is for an in situ organ perfusion system to support rodent brain, liver, and kidney perfusion research, with a completion date of December 31, 2021. Harvard Bioscience Inc. is a manufacturer of specialized scientific instruments and supplies, and is registered as a...
- This federal contract award to Harvard Bioscience, Inc. was issued by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, for the purchase of an AGILEPULSE IM SYSTEM. The $38,316.70 firm fixed-price purchase order does not have a set-aside designation. Harvard Bioscience, a for-profit small disadvantaged business, manufactures a range of specialized scientific instruments and equipment for federal...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services (HHS) to Denville Scientific, Inc., a subsidiary of Harvard Bioscience Inc. The $5,309.04 contract does not have a set-aside designation and was awarded on November 6, 2014 with a completion date of November 21, 2014. The award supports the provision of specialized scientific products, apparatus, and instruments used in biomedical...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Denville Scientific, Inc., a subsidiary of Harvard Bioscience Inc. The contract, valued at $7,444.00, is a Blanket Purchase Agreement (BPA) call order for the procurement of laboratory equipment. The contract does not have a set-aside designation. The parent company, Harvard Bioscience Inc., is a global developer, manufacturer, and...
- This federal contract award is for the procurement of a BTX GEMINI X2 SYSTEM from Harvard Bioscience Inc.'s Harvard Apparatus Division. The $9,040.50 firm fixed-price purchase order was awarded on August 31, 2016 by the Northeast Area division of a civilian federal agency, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Harvard Bioscience Inc. is a global developer, manufacturer, and marketer of specialized scientific products,...
- This federal contract award to Harvard Bioscience Inc. (Harvard Apparatus Division) is for the procurement of a Microelectrode Array (MEA) System. The contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) and has a firm fixed price of $129,610.55. Harvard Bioscience is a global developer, manufacturer, and marketer of specialized products, apparatus, and scientific instruments used for basic research, drug discovery, clinical and...
- Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $8,320.00 from the Defense Health Agency on May 4, 2022, with an ultimate completion date of July 31, 2023. This firm fixed-price task order was issued under Harvard Bioscience's single-award, $4.8 million BPA with the Defense Health Agency, which was awarded on the same date with a completion extending through May 3, 2027. The call order...
This is a firm fixed-price purchase order awarded by the National Cancer Institute, an agency within the Department of Health and Human Services, to Harvard Bioscience Inc.'s Harvard Apparatus division. The $11,109.53 award is for the delivery of specialized scientific products, apparatus, and instruments used in biomedical research across various disciplines such as neuroscience, oncology, and cardiovascular studies. Harvard Bioscience Inc. is a global developer, manufacturer, and marketer of these types of research products and has been awarded numerous federal contracts, including a $4.8 million Blanket Purchase Agreement with the Defense Health Agency to provide a wide range of biomedical equipment, devices, software, and related services. This award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($20) | 9/29/25 | |
| Not listed | Not listed | $11.1k | 7/21/20 |